Great Tree Pharmacy Co., Ltd. (TPEX: 6469)
165.00
-6.50 (-3.79%)
Sep 10, 2024, 1:30 PM CST
Great Tree Pharmacy Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 16,690 | 16,144 | 14,565 | 11,281 | 8,641 | 6,602 | Upgrade
|
Revenue Growth (YoY) | 9.13% | 10.84% | 29.11% | 30.55% | 30.90% | 34.71% | Upgrade
|
Cost of Revenue | 12,042 | 11,658 | 10,554 | 8,338 | 6,457 | 5,006 | Upgrade
|
Gross Profit | 4,648 | 4,486 | 4,011 | 2,943 | 2,185 | 1,596 | Upgrade
|
Selling, General & Admin | 3,836 | 3,680 | 3,149 | 2,451 | 1,959 | 1,453 | Upgrade
|
Operating Expenses | 3,836 | 3,680 | 3,149 | 2,451 | 1,959 | 1,453 | Upgrade
|
Operating Income | 812.42 | 805.56 | 861.87 | 492.31 | 225.31 | 142.37 | Upgrade
|
Interest Expense | -56.42 | -57.5 | -45.85 | -35.13 | -32.87 | -26.94 | Upgrade
|
Interest & Investment Income | 14.4 | 15.88 | 4.32 | 0.74 | 0.58 | 1.01 | Upgrade
|
Earnings From Equity Investments | -1.27 | -0.93 | - | - | - | - | Upgrade
|
Currency Exchange Gain (Loss) | 2.48 | 1.53 | 12.54 | -1.86 | -1.69 | -1.71 | Upgrade
|
Other Non Operating Income (Expenses) | 88.57 | 76.01 | 48.25 | 50.91 | 49.71 | 55.24 | Upgrade
|
EBT Excluding Unusual Items | 860.19 | 840.55 | 881.14 | 506.97 | 241.03 | 169.97 | Upgrade
|
Gain (Loss) on Sale of Investments | -2.41 | -0.72 | -0.43 | - | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | 0.92 | 0.5 | 1.12 | 0.1 | 0.9 | - | Upgrade
|
Other Unusual Items | 0.26 | 1.49 | 0.5 | 2.6 | 1.48 | 1.13 | Upgrade
|
Pretax Income | 858.96 | 841.82 | 882.33 | 509.67 | 243.41 | 171.1 | Upgrade
|
Income Tax Expense | 177.15 | 175.34 | 181.83 | 101.91 | 50.74 | 37.1 | Upgrade
|
Earnings From Continuing Operations | 681.81 | 666.48 | 700.5 | 407.76 | 192.67 | 134 | Upgrade
|
Minority Interest in Earnings | -0.32 | -0.44 | -0.43 | -0.34 | 1.64 | 1.99 | Upgrade
|
Net Income | 681.5 | 666.05 | 700.07 | 407.42 | 194.31 | 135.99 | Upgrade
|
Net Income to Common | 681.5 | 666.05 | 700.07 | 407.42 | 194.31 | 135.99 | Upgrade
|
Net Income Growth | 3.04% | -4.86% | 71.83% | 109.67% | 42.89% | 28.29% | Upgrade
|
Shares Outstanding (Basic) | 131 | 130 | 128 | 126 | 122 | 115 | Upgrade
|
Shares Outstanding (Diluted) | 138 | 138 | 133 | 131 | 126 | 127 | Upgrade
|
Shares Change (YoY) | 1.83% | 4.09% | 1.51% | 3.36% | -0.62% | 5.25% | Upgrade
|
EPS (Basic) | 5.19 | 5.13 | 5.46 | 3.23 | 1.59 | 1.18 | Upgrade
|
EPS (Diluted) | 5.03 | 4.93 | 5.31 | 3.12 | 1.55 | 1.07 | Upgrade
|
EPS Growth | 1.41% | -7.16% | 70.41% | 100.79% | 44.48% | 17.26% | Upgrade
|
Free Cash Flow | 1,034 | 594.08 | 924.01 | 829.21 | 481.48 | -26.82 | Upgrade
|
Free Cash Flow Per Share | 7.48 | 4.30 | 6.96 | 6.34 | 3.81 | -0.21 | Upgrade
|
Dividend Per Share | 3.075 | 3.075 | 3.271 | 1.423 | 0.427 | 0.356 | Upgrade
|
Dividend Growth | -6.00% | -6.00% | 129.88% | 233.36% | 20.02% | -14.86% | Upgrade
|
Gross Margin | 27.85% | 27.79% | 27.54% | 26.09% | 25.28% | 24.17% | Upgrade
|
Operating Margin | 4.87% | 4.99% | 5.92% | 4.36% | 2.61% | 2.16% | Upgrade
|
Profit Margin | 4.08% | 4.13% | 4.81% | 3.61% | 2.25% | 2.06% | Upgrade
|
Free Cash Flow Margin | 6.20% | 3.68% | 6.34% | 7.35% | 5.57% | -0.41% | Upgrade
|
EBITDA | 1,071 | 1,046 | 1,071 | 663.11 | 361.55 | 236.07 | Upgrade
|
EBITDA Margin | 6.41% | 6.48% | 7.35% | 5.88% | 4.18% | 3.58% | Upgrade
|
D&A For EBITDA | 258.13 | 240.04 | 208.92 | 170.8 | 136.24 | 93.7 | Upgrade
|
EBIT | 812.42 | 805.56 | 861.87 | 492.31 | 225.31 | 142.37 | Upgrade
|
EBIT Margin | 4.87% | 4.99% | 5.92% | 4.36% | 2.61% | 2.16% | Upgrade
|
Effective Tax Rate | 20.62% | 20.83% | 20.61% | 20.00% | 20.85% | 21.68% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.